VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents

VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration agreement with CERIMED (European Centre for Research in Medical Imaging) to support the preclinical development of VECT-HORUS’ theragnostic agents. More info here.